Lambert JR |
Pharmacology of the gastric mucosa: a rational approach to Helicobacter polytherapy. |
1996 |
Gastroenterology |
pmid:8690219
|
Bates JH |
Mycobacterium avium disease: progress at last. |
1996 |
Am. J. Respir. Crit. Care Med. |
pmid:8665029
|
Wallace RJ et al. |
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. |
1996 |
Am. J. Respir. Crit. Care Med. |
pmid:8665032
|
Frothingham R |
Clarithromycin treatment for Mycobacterium avium-intracellulare complex lung disease. |
1996 |
Am. J. Respir. Crit. Care Med. |
pmid:8665069
|
Treille S et al. |
Kidney graft dysfunction after drug interaction between clarithromycin and cyclosporin. |
1996 |
Nephrol. Dial. Transplant. |
pmid:8672003
|
Araki J et al. |
[A case of Mounier-Kuhn syndrome]. |
1996 |
Nippon Naika Gakkai Zasshi |
pmid:8708483
|
Lowe SH et al. |
Uveitis during treatment of disseminated Mycobacterium avium-intracellulare complex infection with the combination of rifabutin, clarithromycin and ethambutol. |
1996 |
Neth J Med |
pmid:8710040
|
Vasquez A et al. |
Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format. The Gastrointestinal Physiology Working Group of Universidad Peruana Cayetano Heredia and the Johns Hopkins University. |
1996 |
J. Clin. Microbiol. |
pmid:8727909
|
O'Hara K and Yamamoto K |
Reaction of roxithromycin and clarithromycin with macrolide-inactivating enzymes from highly erythromycin-resistant Escherichia coli. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849224
|
Darouiche RO et al. |
Recurrent disseminated infection with Mycobacterium avium complex identified in tissues by molecular analysis. |
1996 |
Clin. Infect. Dis. |
pmid:8729215
|
Flurer CL |
Analysis of macrolide antibiotics by capillary electrophoresis. |
1996 |
Electrophoresis |
pmid:8900943
|
Gillum JG et al. |
Effect of clarithromycin on the pharmacokinetics of 2',3'-dideoxyinosine in patients who are seropositive for human immunodeficiency virus. |
1996 |
Clin. Infect. Dis. |
pmid:8729217
|
Segreti J et al. |
In vitro activity of macrolides against intracellular Legionella pneumophila. |
1996 |
Diagn. Microbiol. Infect. Dis. |
pmid:8902407
|
Dalla Libera M et al. |
High effectiveness and safety of one-week antibiotic regimen in Helicobacter pylori eradication. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8730251
|
Vermot D et al. |
Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8851620
|
Craig AM et al. |
Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin. |
1996 |
Pharmacoeconomics |
pmid:10160472
|
|
[Management of atypical Mycobacterium infections in AIDS-patients]. |
1996 |
Internist (Berl) |
pmid:9131082
|
Cadranel JF et al. |
[Acute symptomatic cytolytic hepatitis probably related to clarithromycin]. |
1996 |
Gastroenterol. Clin. Biol. |
pmid:9119179
|
Ednie LM et al. |
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843313
|
Conte JE et al. |
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807050
|
Nash KA and Inderlied CB |
Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807078
|
Xu G et al. |
Effect of macrolide antibiotics on macrophage functions. |
1996 |
Microbiol. Immunol. |
pmid:8865152
|
Tomioka H et al. |
[Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones]. |
1996 |
Kekkaku |
pmid:8999135
|
Tsuyuguchi K |
[In vitro anti-MAC activities of new quinolones in focus (1)]. |
1996 |
Kekkaku |
pmid:8999136
|
Sakatani M |
[Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (1) Continuous positive cases (failure of the initial chemotherapy)]. |
1996 |
Kekkaku |
pmid:8999139
|
Tanaka E |
[Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial]. |
1996 |
Kekkaku |
pmid:8999140
|
Bock H and Mares A |
[Good results with Helicobacter pylori eradication for treatment of non-ulcer dyspepsia]. |
1996 |
Leber Magen Darm |
pmid:9005302
|
Tursi A et al. |
Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication. |
1996 |
Panminerva Med |
pmid:9009677
|
MacFarlane JT et al. |
Comparison of amoxycillin and clarithromycin as initial treatment of community-acquired lower respiratory tract infections. |
1996 |
Br J Gen Pract |
pmid:8983255
|
Hachem CY et al. |
Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. |
1996 |
Diagn. Microbiol. Infect. Dis. |
pmid:8988762
|
Schimkat M et al. |
Rifabutin-associated anterior uveitis in patients infected with human immunodeficiency virus. |
1996 |
Ger J Ophthalmol |
pmid:8854102
|
Chiba N |
Omeprazole and clarithromycin with and without metronidazole for the eradication of Helicobacter pylori. |
1996 |
Am. J. Gastroenterol. |
pmid:8855737
|
Engelhardt E et al. |
[Postoperative infection with Mycobacterium chelonae]. |
1996 |
Hautarzt |
pmid:9036143
|
Kelleher P et al. |
Uveitis associated with rifabutin and macrolide therapy for Mycobacterium avium intracellulare infection in AIDS patients. |
1996 |
Genitourin Med |
pmid:9038637
|
Torresin A et al. |
Vinca alkaloids and macrolides in human immunodeficiency virus-related malignancies: a safe association. |
1996 |
Cancer Chemother. Pharmacol. |
pmid:8995518
|
Thompson D and Oster G |
Use of terfenadine and contraindicated drugs. |
1996 |
JAMA |
pmid:8614120
|
Sjöström JE and Larsson H |
Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant. |
1996 |
J. Med. Microbiol. |
pmid:8636959
|
|
Clarithromycin and omeprazole for Helicobacter pylori. |
1996 |
Med Lett Drugs Ther |
pmid:8637481
|
Asnis DS et al. |
Mycobacterium avium-intracellulare complex pneumonia in a non-HIV-infected individual: an increasingly recognized disease. |
1996 |
South. Med. J. |
pmid:8638183
|
Pozniak A and Nelson MR |
Against the proposition: all patients with advanced HIV disease should be offered rifabutin prophylaxis. |
1996 |
Genitourin Med |
pmid:8976832
|
Spadaccini A et al. |
Omeprazole versus ranitidine: short-term triple-therapy in patients with Helicobacter pylori-positive duodenal ulcers. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8899094
|
Horowitz RS et al. |
Clinical ergotism with lingual ischemia induced by clarithromycin-ergotamine interaction. |
1996 |
Arch. Intern. Med. |
pmid:8607732
|
Labenz J et al. |
[Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough?]. |
1996 |
Dtsch. Med. Wochenschr. |
pmid:8565802
|
Goh KL et al. |
Helicobacter pylori eradication with short-term therapy leads to duodenal ulcer healing without the need for continued acid suppression therapy. |
1996 |
Eur J Gastroenterol Hepatol |
pmid:8804868
|
Berger C et al. |
Treatment of nontuberculous mycobacterial lymphadenitis with clarithromycin plus rifabutin. |
1996 |
J. Pediatr. |
pmid:8774511
|
Sito E et al. |
One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients. |
1996 |
J. Physiol. Pharmacol. |
pmid:8777303
|
Gabryelewicz A |
Critical evaluation of the treatment of peptic ulcer diseases associated with Helicobacter pylori infection. |
1996 |
J. Physiol. Pharmacol. |
pmid:8777307
|
Deltenre M et al. |
Strategies for Helicobacter pylori eradication in 1995: a review of international and Belgian experience. |
1996 |
J. Physiol. Pharmacol. |
pmid:8777308
|
Roesch W |
Cost-effectiveness of H. pylori eradication. |
1996 |
J. Physiol. Pharmacol. |
pmid:8777309
|
Plemmons RM et al. |
Otitis media and mastoiditis due to Mycobacterium fortuitum: case report, review of four cases, and a cautionary note. |
1996 |
Clin. Infect. Dis. |
pmid:8783722
|
Bagarazzi ML et al. |
Pulmonary Mycobacterium gordonae infection in a two-year-old child: case report. |
1996 |
Clin. Infect. Dis. |
pmid:8783736
|
Santander C et al. |
Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. |
1996 |
Am. J. Gastroenterol. |
pmid:8759659
|
Rana KZ et al. |
Clarithromycin does not affect phosphorylation of zidovudine in vitro. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843311
|
Tursi A et al. |
Short-term low-dose triple therapy with lansoprazole plus amoxycillin and clarithromycin for Helicobacter pylori eradication. |
1996 |
Am. J. Gastroenterol. |
pmid:8759696
|
Flamm RK et al. |
Kill kinetics of antimicrobial agents against Helicobacter pylori. |
1996 |
J. Antimicrob. Chemother. |
pmid:8937967
|
Bermudez LE et al. |
Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model. |
1996 |
J. Infect. Dis. |
pmid:8940212
|
Nagashima R et al. |
Regression of duodenal mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori. |
1996 |
Gastroenterology |
pmid:8942749
|
Ferguson PJ and Saulsbury FT |
Successful treatment of chronic Mycobacterium abscessus otitis media with clarithromycin. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8866816
|
Giacometti A et al. |
In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum. |
1996 |
J. Antimicrob. Chemother. |
pmid:8889715
|
Tracy TS and Johns M |
Comment: delirium probably induced by clarithromycin in a patient receiving fluoxetine. |
1996 |
Ann Pharmacother |
pmid:8893135
|
Ghebremichael S et al. |
Antimycobacterial synergism of clarithromycin and rifabutin. |
1996 |
Scand. J. Infect. Dis. |
pmid:8893404
|
Yousfi MM et al. |
Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy). |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8871452
|
Fisher M et al. |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. |
1996 |
Int J STD AIDS |
pmid:8876354
|
Gross U and Pohl F |
Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii. |
1996 |
Curr. Top. Microbiol. Immunol. |
pmid:8791704
|
Peterson WL et al. |
Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791947
|
Delchier JC et al. |
Omeprazole-amoxycillin versus omeprazole-amoxycillin-clarithromycin in the eradication of Helicobacter pylori. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791948
|
Jaup BH and Norrby A |
Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of H. pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791950
|
Weldon MJ et al. |
A seven-day Helicobacter pylori treatment regimen using clarithromycin, omeprazole and tripotassium dicitrato bismuthate. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791951
|
Tursi A et al. |
Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791952
|
Pierce M et al. |
A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. |
1996 |
N. Engl. J. Med. |
pmid:8663871
|
Rastogi N et al. |
In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. |
1996 |
Curr. Microbiol. |
pmid:8672093
|
Blomgren K and Alván G |
[New guidelines from the Medical Products Agency: the triple regime against Helicobacter pylori is necessary. Treat only if the ulcer is verified]. |
1996 |
Lakartidningen |
pmid:8656812
|
Bachelez H et al. |
Disseminated varioliform pustular eruption due to Mycobacterium avium intracellulare in an HIV-infected patient. |
1996 |
Br. J. Dermatol. |
pmid:8733397
|
Mehaffey PC et al. |
Evaluation of in vitro spectra of activity of azithromycin, clarithromycin, and erythromycin tested against strains of Neisseria gonorrhoeae by reference agar dilution, disk diffusion, and Etest methods. |
1996 |
J. Clin. Microbiol. |
pmid:8789046
|
Heifets LB |
Clarithromycin against Mycobacterium avium complex infections. |
1996 |
Tuber. Lung Dis. |
pmid:8733409
|
Deltenre M et al. |
[How to eradicate Helicobacter pylori in 1995? Critical review of available treatments]. |
1996 |
Gastroenterol. Clin. Biol. |
pmid:8734370
|
Harris AW et al. |
Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971302
|
Moshkowitz M et al. |
One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971304
|
Laine L et al. |
Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971306
|
Naoki K et al. |
[Two cases of pulmonary disease caused by Mycobacterium chelonae subsp. abscessus]. |
1996 |
Nihon Kyobu Shikkan Gakkai Zasshi |
pmid:8976085
|
Iwata M et al. |
[Bronchiolitis obliterans preceding rheumatoid arthritis: effect of clarithromycin]. |
1996 |
Nihon Kyobu Shikkan Gakkai Zasshi |
pmid:8976086
|
Pinzani V et al. |
[Occurrence of anterior uveitis in a HIV patient treated with rifabutin, ethambutol, clarithromycin]. |
1995 Sep-Oct |
Therapie |
pmid:8571297
|
Dalston MO et al. |
[Clarithromycin combined with pyrimethamine in cerebral toxoplasmosis--a report of 2 cases]. |
1995 Oct-Dec |
Rev. Soc. Bras. Med. Trop. |
pmid:8668843
|
Sternon J et al. |
Azithromycin compared with clarithromycin in the treatment of adult patients with acute purulent tracheobronchitis: a cost of illness study. |
1995 Nov-Dec |
J. Int. Med. Res. |
pmid:8746608
|
Stein GE et al. |
A preliminary study of clarithromycin versus doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis. |
1995 Nov-Dec |
Pharmacotherapy |
pmid:8602379
|
Hashisaki GT |
Update on macrolide antibiotics. |
1995 May-Jun |
Am J Otolaryngol |
pmid:7661309
|
Kees F et al. |
Serum and cellular pharmacokinetics of clarithromycin 500 mg q.d. and 250 mg b.i.d. in volunteers. |
1995 May-Jun |
Infection |
pmid:7499006
|
Claussen DW |
The most commonly prescribed medications in the United States: Part 3. |
1995 Jul-Aug |
Gastroenterol Nurs |
pmid:7654815
|
Savarino V et al. |
Helicobacter pylori eradication and reinfection. |
1995 |
Lancet |
pmid:7783564
|
Weits J and Sprenger HG |
[Surgical treatment of lymphadenitis caused by non-tuberculous mycobacteria in children]. |
1995 |
Ned Tijdschr Geneeskd |
pmid:8524431
|
Nash KA and Inderlied CB |
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8592991
|
Katelaris PH et al. |
A randomized prospective comparison of clarithromycin versus amoxycillin in combination with omeprazole for eradication of Helicobacter pylori. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605864
|
Yousfi MM et al. |
Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605865
|
Chevalley GF et al. |
[Uveitis associated with rifabutin treatment. Apropos of 3 patients]. |
1995 |
Klin Monbl Augenheilkd |
pmid:7609395
|
Blum AL et al. |
[Functional dyspepsia: approaches to Helicobacter pylori eradication therapy]. |
1995 |
Leber Magen Darm |
pmid:7609589
|
Deltenre M et al. |
Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574734
|
Fukuda Y et al. |
Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574735
|
Graham DY |
Clarithromycin for treatment of Helicobacter pylori infections. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574737
|
Pavlopoulou J et al. |
Randomized controlled study of clarithromycin versus cefaclor suspensions in the treatment of acute otitis media in children. |
1995 |
J Chemother |
pmid:8904139
|
Wallace RJ et al. |
Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection. |
1995 |
J. Infect. Dis. |
pmid:7876634
|